NOVONIX Statistics
Total Valuation
NOVONIX has a market cap or net worth of $52.51 million. The enterprise value is $84.75 million.
| Market Cap | 52.51M |
| Enterprise Value | 84.75M |
Important Dates
The next estimated earnings date is Monday, October 26, 2026.
| Earnings Date | Oct 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NOVONIX has 991.56 million shares outstanding. The number of shares has increased by 41.30% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 991.56M |
| Shares Change (YoY) | +41.30% |
| Shares Change (QoQ) | +17.70% |
| Owned by Insiders (%) | 3.79% |
| Owned by Institutions (%) | 22.30% |
| Float | 850.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.35 |
| Forward PS | n/a |
| PB Ratio | 0.33 |
| P/TBV Ratio | 0.36 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 15.09 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.97, with a Debt / Equity ratio of 0.58.
| Current Ratio | 0.97 |
| Quick Ratio | 0.88 |
| Debt / Equity | 0.58 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.89 |
Financial Efficiency
Return on equity (ROE) is -65.64% and return on invested capital (ROIC) is -14.00%.
| Return on Equity (ROE) | -65.64% |
| Return on Assets (ROA) | -12.90% |
| Return on Invested Capital (ROIC) | -14.00% |
| Return on Capital Employed (ROCE) | -27.56% |
| Weighted Average Cost of Capital (WACC) | 10.97% |
| Revenue Per Employee | $29,256 |
| Profits Per Employee | -$506,373 |
| Employee Count | 192 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 2.84 |
Taxes
In the past 12 months, NOVONIX has paid $25,542 in taxes.
| Income Tax | 25,542 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.96% in the last 52 weeks. The beta is 1.03, so NOVONIX's price volatility has been similar to the market average.
| Beta (5Y) | 1.03 |
| 52-Week Price Change | -89.96% |
| 50-Day Moving Average | 2.99 |
| 200-Day Moving Average | 6.26 |
| Relative Strength Index (RSI) | 24.03 |
| Average Volume (20 Days) | 20,807 |
Short Selling Information
The latest short interest is 410,013, so 1.77% of the outstanding shares have been sold short.
| Short Interest | 410,013 |
| Short Previous Month | 419,963 |
| Short % of Shares Out | 1.77% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 12.69 |
Income Statement
In the last 12 months, NOVONIX had revenue of $5.62 million and -$97.22 million in losses. Loss per share was -$5.12.
| Revenue | 5.62M |
| Gross Profit | 3.12M |
| Operating Income | -52.00M |
| Pretax Income | -98.82M |
| Net Income | -97.22M |
| EBITDA | -47.46M |
| EBIT | -52.00M |
| Loss Per Share | -$5.12 |
Balance Sheet
The company has $59.53 million in cash and $91.32 million in debt, with a net cash position of -$31.78 million or -$0.03 per share.
| Cash & Cash Equivalents | 59.53M |
| Total Debt | 91.32M |
| Net Cash | -31.78M |
| Net Cash Per Share | -$0.03 |
| Equity (Book Value) | 157.34M |
| Book Value Per Share | 0.16 |
| Working Capital | -2.53M |
Cash Flow
In the last 12 months, operating cash flow was -$43.00 million and capital expenditures -$35.15 million, giving a free cash flow of -$78.15 million.
| Operating Cash Flow | -43.00M |
| Capital Expenditures | -35.15M |
| Depreciation & Amortization | 4.55M |
| Net Borrowing | 93.27M |
| Free Cash Flow | -78.15M |
| FCF Per Share | -$0.08 |
Margins
| Gross Margin | 55.49% |
| Operating Margin | -925.82% |
| Pretax Margin | -1,759.29% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NOVONIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -41.30% |
| Shareholder Yield | -41.30% |
| Earnings Yield | -254.84% |
| FCF Yield | -148.81% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 198.90% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 27, 2026. It was a reverse split with a ratio of 1:10.
| Last Split Date | Aug 27, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
NOVONIX has an Altman Z-Score of -1.44 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.44 |
| Piotroski F-Score | 4 |